Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases

Prostate Cancer and Prostatic Diseases, Published online: 14 September 2022; doi:10.1038/s41391-022-00588-5Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases

Source: Prostate Cancer and Prostatic Diseases - September 14, 2022 Category: Urology & Nephrology Authors: Martin W. Schoen Kenneth R. Carson Seth A. Eisen Charles L. Bennett Suhong Luo Melissa A. Reimers Eric M. Knoche Alison L. Whitmer Yan Yan Bettina F. Drake Kristen M. Sanfilippo Source Type: research